Choose Your Country or Region

Eicosapentaenoic Acid (EPA)

Name: Eicosapentaenoic Acid (EPA)
Brand: Selleck Chemicals
SKU: S6476
Rating: 5 (1 reviews)

Synonyms: Timnodonic Acid

Catalog No.S6476 Purity:99.16%

Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid with antiinflammatory properties, and is present in fish and fish oils, including salmon, cod, and krill oils.

Eicosapentaenoic Acid (EPA) Chemical Structure

CAS No. 10417-94-4

Purity & Quality Control

Batch: Purity: 99.16%

99.16

Eicosapentaenoic Acid (EPA) Related Products

Related Products	Cl-amidine TAPI-1 Bindarit Tempol Anti-mouse CD8α-InVivo Tranilast Sinomenine Geniposidic acid GI254023X CORM-3 Bestatin (Ubenimex) ATP Acacetin Germacrone Oxymatrine Gastrodin Atractylenolide I Y-320 Sinomenine hydrochloride Tomatidine Hydrochloride Thymoquinone Demethylzeylasteral (T-96) Lupeol Flufenamic acid Quercitrin Laquinimod Iguratimod Calycosin Sanguinarine Punicalagin Z-Guggulsterone Fenamic acid Tiragolumab (anti-TIGIT) Geniposide Thymol Jujuboside A PMX-53 6-Shogaol Isoliensinine Tiaprofenic acid Arachidonic acid Astragalin Linarin Isoliquiritin Coumarin Platycodin D Pipecolic acid Umbelliferone Thymopentin Salvianolic acid A VGX-1027 Sinigrin Isovitexin Buddlejasaponin IVb Lysionotin Liensinine Ginsenoside CK Lentinan Wogonoside Bakuchiol Carnosol Madecassic acid Acetylharpagide Anwuligan Ginkgetin Tryptanthrin Pranlukast	Click to Expand
Related Compound Libraries	Kinase Inhibitor Library FDA-approved Drug Library Natural Product Library Bioactive Compound Library-I Highly Selective Inhibitor Library	Click to Expand

Biological Activity

Description	Eicosapentaenoic acid (EPA) is an omega-3 polyunsaturated fatty acid with antiinflammatory properties, and is present in fish and fish oils, including salmon, cod, and krill oils.

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2024-05-22)
NCT06274788	Not yet recruiting	Parenteral Nutrition Associated Liver Disease (PNALD)\|Essential Fatty Acid Deficiency\|Malnutrition\|Pediatric ALL	Fresenius Kabi	May 1 2024	Phase 4
NCT06120985	Recruiting	Water-Related Diseases\|Enteric Pathogens\|Exposure to Chemical Pollution	Virginia Polytechnic Institute and State University\|East Tennessee State University\|University of North Carolina Chapel Hill\|Ballad Health	November 19 2023	Not Applicable
NCT05755997	Recruiting	Cadasil	Ever Neuro Pharma GmbH\|idv Datenanalyse & Versuchsplanung\|XClinical GmbH	November 29 2023	Phase 2

Chemical Information & Solubility

Molecular Weight	302.45	Formula	C₂₀H₃₀O₂
CAS No.	10417-94-4	SDF	--
Smiles	CCC=CCC=CCC=CCC=CCC=CCCCC(=O)O
Storage (From the date of receipt)	2 years -20°C liquid	Storage of Stock Solutions Aliquot the stock solutions to avoid repeated freeze-thaw cycles	1 year-80°Cin solvent
Storage (From the date of receipt)	2 years -20°C liquid		1 month-20°Cin solvent

In vitro
Batch:

DMSO : 60 mg/mL ( (198.37 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble

Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.

In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass	Concentration	Volume	Molecular Weight
=	×	×

Dilution Calculator Molecular Weight Calculator

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):